Use of Weightbearing Radiographs to Determine Treatment of bi- and Trimalleolar Ankle Fractures

August 7, 2023 updated by: Ostfold Hospital Trust
The aim of this study is to evaluate the outcomes after non-operative treatment of weightbearing stable bi-and trimalleolar ankle fractures.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • -With bi- and trimalleolar ankle fractures with less than 7 mm medial clear space on non-weightbearing radiographs that are deemed stable by weightbearing radiographs.
  • With type B medial malleolus fractures between the tip and the plafond and type C medial malleolus fractures at the level of the plafond (Herscovici classification). (6)
  • With fractures in the distal 1/3 of fibula (not-Maisonneuve)
  • Enabling stability evaluation within 14 days after injury
  • 18-75 years of age
  • with pre-injury walking ability without aids

Exclusion Criteria:

  • - With primary unstable ankle fractures, > 7mm medial clear space on primary radiographs
  • With fracture reduction prior to initial radiographic evaluation, open fracture, fractures resulting from high-energy trauma or multi trauma and pathological fracture
  • With type A medial malleolus avulsion fractures < 5mm (at the tip of the malleolus), that are not suitable for surgical intervention.
  • With Herscovici type D fractures, involving Lauge-Hansen SA2 fractures (supracollicular fracture - vertical, oblique or transverse direction of the plafond)
  • With displaced posterior malleolus fractures that needs fixation in the judgement of the attending surgeon
  • With neuropathies and symptomatic joint diseases such as Rheumatoid Arthritis
  • That are assumed not compliant (such as drug abuse, cognitive- and/or psychiatric disorders)
  • With previous history ipsilateral ankle fracture
  • With previous history ipsilateral major ankle-/foot surgery
  • Who live outside the hospital catchment areas not available to follow up
  • With insufficient Norwegian or English language skills
  • Non-compliant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Non-operative treatment
Non-operative treatment based on weightbearing radiographs
Patients will be treated with a walker-orthosis for 6 weeks. Weightbearing as tolerated

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Olerud Molander Score (OMAS) to measure a change over time
Time Frame: 6 week, 12 weeks, 1year, 2 years
Condition specific, patient reported measure of ankle-fracture symptoms
6 week, 12 weeks, 1year, 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manchester-Oxford Foot Questionnaire (MOxFQ)
Time Frame: 6 week, 12 weeks, 1year, 2 years
Patients reported outcomes
6 week, 12 weeks, 1year, 2 years
Range of Motion measured by a goniometer (ad modum Lindsjo)
Time Frame: 6 week, 12 weeks, 1year, 2 years
dorsiflexion and plantarflexion
6 week, 12 weeks, 1year, 2 years
Numeric Rating Scale (NRS)
Time Frame: 6 week, 12 weeks, 1year, 2 years
Ankle pain in rest, at night and in daily activities, a 11-point numeric scale ranging from 0-10
6 week, 12 weeks, 1year, 2 years
Euroqol questionnaire (EQ- 5D)
Time Frame: 6 week, 12 weeks, 1year, 2 years
Health related quality of life
6 week, 12 weeks, 1year, 2 years
Registrations of complications/adverse events
Time Frame: 0-2 years
Registration of loss of congruence, delayed union, non-union, thromboembolic events
0-2 years
Posttraumatic osteoarthritis (OA)
Time Frame: 2 years and 5 years
CT-scan (Kellgren-Lawrence classification)
2 years and 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2032

Study Registration Dates

First Submitted

February 27, 2023

First Submitted That Met QC Criteria

March 9, 2023

First Posted (Actual)

March 13, 2023

Study Record Updates

Last Update Posted (Actual)

August 8, 2023

Last Update Submitted That Met QC Criteria

August 7, 2023

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 47891

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Fracture, Trimalleolar

Clinical Trials on Non-operative treatment

3
Subscribe